What is Lifecore Biomedical, Inc.'s EBITDA margin?

Lifecore Biomedical, Inc. (LFCR) reported EBITDA margin of -12.2% in Q1 2025.

What is the long-term trend for Lifecore Biomedical, Inc.'s EBITDA margin?

Over 3 years (2021 to 2025), Lifecore Biomedical, Inc.'s EBITDA margin has grown at a 52.6% compound annual growth rate (CAGR), from 3.4% to -12.2%.

What does EBITDA margin mean?

EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.

Lifecore Biomedical, Inc. LFCR EBITDA margin

EBITDA margin at other companies

Baxter InternationalBAX

5.9%-6.2pp

Thermo Fisher ScientificTMO

24.2%-0.2pp

ADMA BiologicsADMA

43.7%+8.9pp

Medpace Holdings, Inc.MEDP

22.1%-0.4pp

Biodesix, Inc.BDSX

-20.1%-6.2pp

ClearPoint NeuroCLPT

-63.2%-1.4pp

Other financials

Income statement

See full

Revenue$23.2M-36.4%

Gross profit$4.5M-68.1%

Operating income-$4.7M—

Net income-$15.0M-1,206%

EPS (diluted)-$0.43-1,333%

Balance sheet

See full

Cash & equivalents$20.8M+152%

Total debt$156.9M+1,310%

Total equity-$28.4M-2,229%

Total assets$225.5M-5.8%

Cash flow

See full

Operating cash flow$4.7M—

CapEx$1.1M-46.7%

Free cash flow$3.6M—

Valuation

See full

Market cap$196.92M-35.4%

Enterprise value$333.06M+8.3%

P/S1.6×+0.5×

Profitability

See full

Gross margin31.3%-1.4pp

Operating margin-14.5%-2.2pp

Net margin-30%—

FCF margin-36.4%—

Returns & leverage

See full

Return on equity-612.1%—

Debt / equity8.3×-1.5×

Current ratio3.8×+0.9×

Where this comes from

Calculated from Lifecore Biomedical, Inc.’s reported figures.

ebitda/total revenue=-12.2%

Based on trailing twelve months.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s EBITDA margin?: Lifecore Biomedical, Inc. (LFCR) reported EBITDA margin of -12.2% in Q1 2025.
What is the long-term trend for Lifecore Biomedical, Inc.'s EBITDA margin?: Over 3 years (2021 to 2025), Lifecore Biomedical, Inc.'s EBITDA margin has grown at a 52.6% compound annual growth rate (CAGR), from 3.4% to -12.2%.
What does EBITDA margin mean?: EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.